Which agency oversees research misconduct investigations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is C. Office of Research Integrity. The Office of Research Integrity (ORI) is the primary federal agency responsible for overseeing investigations of alleged research misconduct in biomedical and behavioral research supported by the U.S. Department of Health and Human Services (HHS) 1. ORI specifically handles cases involving fabrication, falsification, or plagiarism in research funded by agencies like the National Institutes of Health. While the FDA and CDER have regulatory oversight roles in their respective domains, they do not have the primary responsibility for investigating research misconduct allegations. The NIH funds research but refers misconduct investigations to ORI. Understanding this distinction is important for researchers and clinical trial staff seeking GCP certification, as it clarifies the reporting structure and accountability mechanisms for maintaining research integrity in federally funded studies. Key points to consider include:

  • The role of ORI in investigating research misconduct
  • The distinction between regulatory oversight and research misconduct investigation
  • The importance of understanding the reporting structure and accountability mechanisms for research integrity. Note that the study from 2009 1 does not provide relevant information for this question, as it focuses on combating extensively drug-resistant tuberculosis and does not address research misconduct investigations.

From the Research

Agencies Overseeing Investigations of Alleged Research Misconduct

  • The Office of Research Integrity (ORI) is responsible for protecting the integrity of research supported by grants awarded for the Public Health Service extramural research program 2.
  • ORI monitors investigations into alleged or suspected scientific misconduct by institutions that receive Public Health Service funds 2, 3.
  • ORI oversees institutional efforts to investigate and report misconduct, and recommends administrative actions when misconduct is identified 3.
  • The role of the research institution in responding to misconduct and promoting research integrity is complementary and overlapping with ORI's efforts 3.
  • While other agencies such as the Food and Drug Administration and the National Institutes of Health may be involved in research oversight, the Office of Research Integrity is specifically responsible for overseeing investigations of alleged research misconduct 2, 3, 4, 5.
  • Therefore, the correct answer is C. Office of Research Integrity.

Relevant Agencies

  • Office of Research Integrity (ORI): responsible for protecting the integrity of research supported by Public Health Service grants 2, 3, 4, 5.
  • Public Health Service (PHS): provides funds for extramural research grants and has a definition of scientific misconduct 2, 3.
  • National Institutes of Health (NIH): may be involved in research oversight, but is not specifically responsible for overseeing investigations of alleged research misconduct 2, 3.
  • Food and Drug Administration (FDA): may be involved in research oversight, but is not specifically responsible for overseeing investigations of alleged research misconduct 2, 3.
  • Center for Drug Evaluation and Research: may be involved in research oversight, but is not specifically responsible for overseeing investigations of alleged research misconduct 2, 3.

Related Questions

Is C15 (Compound 15) safe and effective for use in humans?
In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
What is the best way to schedule an Emergency Room (ER) with 3 overlapping shifts?
Must every aspect of a research study be documented in compliance with Good Clinical Practice (GCP) guidelines to obtain useful data?
What constitutes research misconduct in the context of Good Clinical Practice (GCP) certification?
What are the clinical, pathological, and molecular characteristics for adding anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
What are the clinical, pathological, and molecular characteristics for adding anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
Can nitrofurantoin be used to treat uncomplicated urinary tract infections (UTIs) caused by Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (E. coli)?
What is the cause of a rash on the legs of a 36-year-old woman?
Will diclofenac (Voltaren) gel help with Tietze's syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.